Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer. (Record no. 19446823)

MARC details
000 -LEADER
fixed length control field 01598 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515203047.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-1827
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/sj.bjc.6605507
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Trarbach, T
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100223
245 00 - TITLE STATEMENT
Title Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of cancer
Date of publication, distribution, etc. Feb 2010
300 ## - PHYSICAL DESCRIPTION
Extent 506-12 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colorectal Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunohistochemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, TNF-Related Apoptosis-Inducing Ligand
General subdivision agonists
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moehler, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Heinemann, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Köhne, C-H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Przyborek, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schulz, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sneller, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gallant, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kanzler, S
773 0# - HOST ITEM ENTRY
Title British journal of cancer
Related parts vol. 102
-- no. 3
-- p. 506-12
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/sj.bjc.6605507">https://doi.org/10.1038/sj.bjc.6605507</a>
Public note Available from publisher's website

No items available.